Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Apriglim-M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Aprica Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Apriglim-M 0.5 Tablet PR

Diabetol-Duo 0.5mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetol-Duo 0.5mg should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking kidney complications, vision loss, neuropathy, and limb damage. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are vital in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require physician consultation. Regular blood glucose monitoring and periodic blood tests (to check blood cell counts and liver function) are recommended.

Primary Ingredients of Apriglim-M 0.5 Tablet PR

No text provided to rephrase.

Uses of Apriglim-M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Apriglim-M 0.5 Tablet PR:

Follow your doctor's instructions or the product label for proper administration. Consume Apriglim-M 0.5mg Tablet PR with food.

Common Side effects of Apriglim-M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Apriglim-M 0.5 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Consume Apriglim-M 0.5mg Tablet PR with a meal.

How Apriglim-M 0.5 Tablet PR works:

Apriglim-M 0.5mg tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose. Metformin, a biguanide, acts threefold: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Apriglim-M 0.5 mg tablets is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Apriglim-M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The use of Apriglim-M 0.5 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Apriglim-M 0.5 Tablet PR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Apriglim-M 0.5 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Apriglim-M 0.5 Tablet PR cautiously. Dosage modification may be necessary for these patients. Physician consultation is advised. For those with mild to moderate liver disease, Apriglim-M 0.5 Tablet PR is typically initiated at a low dose; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Apriglim-M 0.5 Tablet PR :

Should you forget to take your Apriglim-M 0.5 Tablet PR, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Apriglim-M 0.5 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Apriglim-M 0.5 Tablet PR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Apriglim-M 0.5 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience any of these, discontinue Apriglim-M 0.5 Tablet PR and seek immediate medical attention.
Apriglim-M 0.5 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Apriglim-M 0.5 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Apriglim-M 0.5 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Apriglim-M 0.5 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Apriglim-M 0.5 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Apriglim-M 0.5 Tablet PR
88
MRP 102
13% off